Biochemome Research International, Inc.

Biochemome Research International (BRI) is a research and development organization focused on providing advanced drug discovery tools, databases, and CRO services. The company specializes in cheminformatics, computer-aided drug design (CADD), and data integration services, helping pharmaceutical and biotech companies transform complex chemical and biological data into actionable knowledge. BRI offers services including virtual screening, lead design, ADME profiling, and patent consulting. They utilize proprietary search engines and machine learning technologies to assist in the discovery of novel therapeutics, with a particular focus on targets such as kinases, proteases, and nuclear receptors.